NASDAQ:AVR Anteris Technologies Global Q1 2026 Earnings Report $6.48 +0.09 (+1.33%) As of 10:58 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Anteris Technologies Global EPS ResultsActual EPSN/AConsensus EPS -$0.27Beat/MissN/AOne Year Ago EPSN/AAnteris Technologies Global Revenue ResultsActual RevenueN/AExpected Revenue$0.77 millionBeat/MissN/AYoY Revenue GrowthN/AAnteris Technologies Global Announcement DetailsQuarterQ1 2026Date5/12/2026TimeBefore Market OpensConference Call DateMonday, May 11, 2026Conference Call Time8:00PM ETConference Call ResourcesEarnings HistoryCompany Profile Anteris Technologies Global Earnings HeadlinesAnteris Technologies enrolls First US patients in global PARADIGM trial for DurAVR heart valveMay 6 at 9:24 PM | finance.yahoo.comAnteris Technologies Global Corp.: Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM TrialMay 6 at 6:21 AM | finanznachrichten.deYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.May 7 at 1:00 AM | Profits Run (Ad)Anteris treats first US patients in DurAVR pivotal trialMay 6 at 6:21 AM | finance.yahoo.comAnteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM TrialMay 5 at 6:00 AM | globenewswire.comAnteris Ends v2vmedtech Development Agreement, Limits ExposureApril 29, 2026 | tipranks.comSee More Anteris Technologies Global Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email. Email Address About Anteris Technologies GlobalAnteris Technologies Global (NASDAQ:AVR) engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.View Anteris Technologies Global ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Why Lam Research Still Looks Like a Buy After a 300% RallySuper Micro Surges Over 20% as Margins Soar, Sales Fall ShortAnheuser-Busch Stock Jumps as Volume Growth Signals TurnaroundLight Speed Returns: Corning Cashes In on NVIDIA GrowthBoarding Passes Now Being Issued for the Ultimate eVTOL ArbitrageDigitalOcean’s AI Surge: How Far Can This Rally Go?Fairy Dust Works: Disney's Stock Price Rises as Business Accelerates Upcoming Earnings AngloGold Ashanti (5/8/2026)Brookfield Asset Management (5/8/2026)Enbridge (5/8/2026)Toyota Motor (5/8/2026)Ubiquiti (5/8/2026)Constellation Energy (5/11/2026)Barrick Mining (5/11/2026)Petroleo Brasileiro S.A.- Petrobras (5/11/2026)Simon Property Group (5/11/2026)SEA (5/12/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
